佰仁医疗：关于自愿披露射频消融系统进入创新医疗器械特别审查程序的公告

Core Viewpoint - The company, Baifen Medical, has announced that its self-developed radiofrequency ablation system has received approval from the National Medical Products Administration (NMPA) to enter the special review process for innovative medical devices [2] Group 1 - The radiofrequency ablation system is a product developed independently by the company [2] - The approval marks a significant step for the company in the medical device sector [2] - The entry into the special review process indicates the potential for expedited evaluation and market entry [2]